Commentary & Perspectives

Meeting the GLP-1 Challenge with High-Resolution Mass Spec

Veloxity Labs and SCIEX team up to advance peptide bioanalysis; here, the teams discuss how the GLP-1 boom is reshaping workflows and raising the bar for analytical performance

By
James Strachan
February 25, 2026
7 min

The Analytical Scientist

1

Peptide therapeutics are rapidly growing, especially GLP-1 agonists.
2

Veloxity Labs adopts SCIEX ZenoTOF 8600 to enhance analytical capabilities.
3

High-resolution MS improves sensitivity and selectivity for peptide analysis.
4

Collaboration is key for addressing changing therapeutic demands.
5

Smaller sample volumes require innovative workflows to ensure reproducibility.
6

Speed and confidence in peptide analysis are improved with new technologies.

Original Source(s)

The Analytical Scientist

Meeting the GLP-1 Challenge with High-Resolution Mass Spec

Veloxity Labs and SCIEX team up to advance peptide bioanalysis; here, the teams discuss how the GLP-1 boom is reshaping workflows and raising the bar for analytical performance

by James Strachan
February 25, 2026
7 min

Related Content

Conexiant

AI Tools Expand in Thyroid Cancer Diagnosis

Uptake will require “compelling evidence that these systems can reduce time and effort while at least maintaining, if not improving, diagnostic accuracy, making the cost of implementation and continued usage worthwhile.”